SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gerald Underwood who wrote (504)10/24/1998 5:13:00 PM
From: Cavalry  Read Replies (1) of 857
 
the pressure that cfs sufferers with no other hope besides ampligen
can exert on fda may be just the kick in the pants the fda needs, how does fast track approval process work and is heb eligible to capitalize on this the way they have with orphan status and cost recovery?

you are right i did have wrong gerald, my apologies on prior post

cav
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext